Tali Konry

Dr. Tali Konry is an Associate Professor and Assistant Dean of Research in the Department of Pharmaceutical Sciences at Northeastern University's Bouvé College of Health Sciences. Her research focuses on developing microfluidic technologies for precision medicine, including lab-on-a-chip systems for single-cell analysis and tumor microenvironment modeling. She leads the Konry Lab, which has pioneered innovations in immunotherapy, drug resistance profiling, and point-of-care diagnostics for cancer and infectious diseases.

Her work has been supported by grants from NIH (R01, R33, U54), NSF, American Heart Association, and Sanofi. Notable achievements include the Sanofi Idea Award (2023/2024), Schumacher Faculty Award, and Phase 1 Finalist status in the NIH Follow That Cell Challenge. Collaborations include partnerships with Dana-Farber Cancer Institute, Boston Children’s Hospital, and NASA for space-based immune studies.

Dr. Konry’s lab has developed cutting-edge platforms such as the CIAMAP modular acoustofluidic system for cellular immunity analysis and droplet-based tools for real-time monitoring of NK-Tumor interactions. She also leads initiatives in personalized cancer treatment through functional omics analysis and microfluidic spheroid models.

Key areas of expertise include:

• Single-cell functional phenotyping
• Droplet microfluidics for high-throughput screening
• Immune cell interaction dynamics
• 3D tumor microenvironment modeling
• Clinical translation of lab-on-a-chip technologies

Her research has produced over 70 peer-reviewed articles and multiple patents, including innovations in droplet sorting, microvalve systems, and acoustofluidic platforms. Current projects include NASA-funded studies on space-induced immune changes and collaborations with industry leaders in immunotherapy development.